Flomax
Product Images NDC 54868-4356

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Flomax (NDC 54868-4356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Flomax Fig1)

A line graph depicting plasma concentration (ng/mL) of Flomax over time (hours) with separate curves for fasted and fed states. The graph shows concentration peaks and declines over a 36-hour period, illustrating the pharmacokinetic profiles under different conditions.*

FDA Label Image

Figure 2a (Flomax Fig2a)

A line graph showing mean change over duration of treatment in weeks, comparing Flomax treatment groups of 0.8 mg and 0.4 mg dosages versus placebo. The graph displays data points with different markers for each group and tracks changes from baseline to 13 weeks and last observation carried forward (LOCF).*

FDA Label Image

Figure 2b (Flomax Fig2b)

A line graph showing mean change over duration of treatment in weeks for Flomax 0.8 mg, 0.4 mg, and placebo groups. The x-axis represents weeks of treatment, and the y-axis shows mean change. Separate lines with symbols indicate treatment groups comparing their effects across the study period.*

FDA Label Image

Figure 3a (Flomax Fig3a)

A line graph depicting mean change in an unspecified measurement (mL/sec) over a duration of 13 weeks plus a Long-Term Open-Label Extension (LOCE). The graph compares three treatments: 0.8 mg, 0.4 mg, and placebo, with mean changes plotted over multiple time points. The 0.8 mg and 0.4 mg treatments show higher mean changes than placebo throughout the study period.*

FDA Label Image

Figure 3b (Flomax Fig3b)

Line graph showing mean change in mL/sec over duration of treatment in weeks, comparing three treatments: 0.8 mg, 0.4 mg, and placebo. The 0.8 mg and 0.4 mg treatments show higher mean changes than placebo across the time points.*

FDA Label Image

Flomax Structure (Flomax Struct)

Chemical structure of the active ingredient found in Flomax, showing the molecular arrangement along with an associated hydrochloride (HCl) group.*

FDA Label Image

Text (Package Label)

Flomax 0.4 mg capsules packaging label by Physicians Total Care, Inc. The label indicates 60 capsules per container, with the active ingredient tamsulosin hydrochloride. The label includes cautions about federal law restricting dispensing without a prescription, storage instructions, and lot and expiration information. The Physicians Total Care logo appears at the top left.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.